Ryman Healthcare Limited
Ryman Healthcare Limited develops, owns, and operates integrated retirement villages, rest homes, and hospitals for the older people in New Zealand and Australia. The company's villages provide apartments and townhouses, and assisted-living in serviced apartments, as well as a care center, which offers rest homes, hospitals, specialist dementia care, and respite care services. Ryman Healthcare Li… Read more
Ryman Healthcare Limited (RHCGF) - Net Assets
Latest net assets as of September 2025: $4.11 Billion USD
Based on the latest financial reports, Ryman Healthcare Limited (RHCGF) has net assets worth $4.11 Billion USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($12.06 Billion) and total liabilities ($7.95 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $4.11 Billion |
| % of Total Assets | 34.04% |
| Annual Growth Rate | 19.85% |
| 5-Year Change | 115.05% |
| 10-Year Change | 220.98% |
| Growth Volatility | 26.94 |
Ryman Healthcare Limited - Net Assets Trend (1999–2025)
This chart illustrates how Ryman Healthcare Limited's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Ryman Healthcare Limited (1999–2025)
The table below shows the annual net assets of Ryman Healthcare Limited from 1999 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-03-31 | $4.26 Billion | -3.54% |
| 2024-03-31 | $4.42 Billion | -5.28% |
| 2023-03-31 | $4.66 Billion | +95.90% |
| 2022-03-31 | $2.38 Billion | +20.16% |
| 2021-03-31 | $1.98 Billion | +45.25% |
| 2020-03-31 | $1.36 Billion | -37.14% |
| 2019-03-31 | $2.17 Billion | +11.83% |
| 2018-03-31 | $1.94 Billion | +17.46% |
| 2017-03-31 | $1.65 Billion | +24.45% |
| 2016-03-31 | $1.33 Billion | +20.54% |
| 2015-03-31 | $1.10 Billion | +18.84% |
| 2014-03-31 | $926.75 Million | +26.18% |
| 2013-03-31 | $734.47 Million | +13.48% |
| 2012-03-31 | $647.22 Million | +14.38% |
| 2011-03-31 | $565.83 Million | +23.93% |
| 2010-03-31 | $456.55 Million | +11.85% |
| 2009-03-31 | $408.20 Million | +9.67% |
| 2008-03-31 | $372.20 Million | +28.90% |
| 2007-03-31 | $288.76 Million | +18.48% |
| 2006-03-31 | $243.72 Million | +31.21% |
| 2005-03-31 | $185.76 Million | +26.38% |
| 2004-03-31 | $146.99 Million | +18.55% |
| 2003-03-31 | $123.99 Million | +10.35% |
| 2002-03-31 | $112.36 Million | +17.38% |
| 2001-03-31 | $95.72 Million | +20.79% |
| 2000-03-31 | $79.24 Million | +106.22% |
| 1999-03-31 | $38.43 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Ryman Healthcare Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 12399.6% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (March 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $2.23 Billion | 52.30% |
| Common Stock | $1.92 Billion | 45.13% |
| Other Comprehensive Income | $109.40 Million | 2.57% |
| Total Equity | $4.26 Billion | 100.00% |
Ryman Healthcare Limited Competitors by Market Cap
The table below lists competitors of Ryman Healthcare Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Acadian Asset Management Inc
NYSE:AAMI
|
$1.39 Billion |
|
Inmobiliaria Colonial SOCIMI S.A.
LSE:0RID
|
$1.39 Billion |
|
Qingdao Sentury Tire Co Ltd
SHE:002984
|
$1.39 Billion |
|
Melco International Development Limited
PINK:MDEVY
|
$1.39 Billion |
|
Jereissati Participações S.A.
SA:IGTI11
|
$1.39 Billion |
|
Betsson AB (publ)
PINK:BTSNY
|
$1.39 Billion |
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SHG:603392
|
$1.39 Billion |
|
Borregaard ASA
PINK:BRRDF
|
$1.39 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Ryman Healthcare Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 4,417,607,000 to 4,261,123,000, a change of -156,484,000 (-3.5%).
- Net loss of 436,831,000 reduced equity.
- New share issuances of 976,516,000 increased equity.
- Other comprehensive income decreased equity by 274,048,000.
- Other factors decreased equity by 422,121,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-436.83 Million | -10.25% |
| Share Issuances | $976.52 Million | +22.92% |
| Other Comprehensive Income | $-274.05 Million | -6.43% |
| Other Changes | $-422.12 Million | -9.91% |
| Total Change | $- | -3.54% |
Book Value vs Market Value Analysis
This analysis compares Ryman Healthcare Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.24x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 3.89x to 0.24x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1999-03-31 | $0.36 | $1.41 | x |
| 2000-03-31 | $0.75 | $1.41 | x |
| 2001-03-31 | $0.90 | $1.41 | x |
| 2002-03-31 | $1.06 | $1.41 | x |
| 2003-03-31 | $1.17 | $1.41 | x |
| 2004-03-31 | $1.39 | $1.41 | x |
| 2005-03-31 | $1.75 | $1.41 | x |
| 2006-03-31 | $2.30 | $1.41 | x |
| 2007-03-31 | $2.88 | $1.41 | x |
| 2008-03-31 | $3.53 | $1.41 | x |
| 2009-03-31 | $3.87 | $1.41 | x |
| 2010-03-31 | $4.32 | $1.41 | x |
| 2011-03-31 | $5.33 | $1.41 | x |
| 2012-03-31 | $6.10 | $1.41 | x |
| 2013-03-31 | $6.92 | $1.41 | x |
| 2014-03-31 | $1.85 | $1.41 | x |
| 2015-03-31 | $2.20 | $1.41 | x |
| 2016-03-31 | $2.66 | $1.41 | x |
| 2017-03-31 | $3.30 | $1.41 | x |
| 2018-03-31 | $3.88 | $1.41 | x |
| 2019-03-31 | $4.34 | $1.41 | x |
| 2020-03-31 | $2.57 | $1.41 | x |
| 2021-03-31 | $3.74 | $1.41 | x |
| 2022-03-31 | $4.49 | $1.41 | x |
| 2023-03-31 | $9.03 | $1.41 | x |
| 2024-03-31 | $6.42 | $1.41 | x |
| 2025-03-31 | $6.00 | $1.41 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Ryman Healthcare Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -10.25%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -61.20%
- • Asset Turnover: 0.06x
- • Equity Multiplier: 2.83x
- Recent ROE (-10.25%) is below the historical average (15.50%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1999 | 16.11% | 52.88% | 0.17x | 1.80x | $2.35 Million |
| 2000 | 15.85% | 27.31% | 0.43x | 1.36x | $4.63 Million |
| 2001 | 14.73% | 24.72% | 0.35x | 1.69x | $4.53 Million |
| 2002 | 9.86% | 18.08% | 0.35x | 1.54x | $-162.60K |
| 2003 | 12.35% | 16.43% | 0.51x | 1.48x | $2.91 Million |
| 2004 | 12.52% | 17.03% | 0.55x | 1.33x | $3.70 Million |
| 2005 | 12.66% | 19.89% | 0.49x | 1.31x | $4.95 Million |
| 2006 | 14.39% | 24.65% | 0.44x | 1.33x | $10.69 Million |
| 2007 | 14.40% | 21.94% | 0.43x | 1.51x | $12.70 Million |
| 2008 | 19.51% | 97.16% | 0.07x | 2.74x | $35.38 Million |
| 2009 | 16.19% | 72.18% | 0.08x | 2.88x | $25.25 Million |
| 2010 | 17.18% | 71.88% | 0.08x | 2.91x | $32.76 Million |
| 2011 | 17.70% | 77.60% | 0.08x | 2.84x | $43.59 Million |
| 2012 | 18.66% | 78.36% | 0.08x | 2.96x | $56.05 Million |
| 2013 | 18.62% | 75.80% | 0.08x | 3.00x | $63.28 Million |
| 2014 | 21.02% | 96.14% | 0.07x | 2.94x | $102.13 Million |
| 2015 | 21.97% | 106.82% | 0.07x | 3.01x | $131.79 Million |
| 2016 | 23.01% | 117.31% | 0.07x | 2.99x | $172.67 Million |
| 2017 | 21.59% | 123.54% | 0.06x | 2.99x | $191.48 Million |
| 2018 | 20.01% | 113.48% | 0.06x | 2.99x | $194.16 Million |
| 2019 | 15.02% | 85.38% | 0.06x | 3.07x | $108.97 Million |
| 2020 | 19.41% | 62.71% | 0.09x | 3.34x | $128.30 Million |
| 2021 | 21.35% | 93.51% | 0.07x | 3.24x | $224.92 Million |
| 2022 | 29.10% | 137.54% | 0.07x | 3.19x | $454.79 Million |
| 2023 | 5.53% | 46.03% | 0.04x | 2.68x | $-208.55 Million |
| 2024 | 0.11% | 0.73% | 0.05x | 2.96x | $-436.99 Million |
| 2025 | -10.25% | -61.20% | 0.06x | 2.83x | $-862.94 Million |
Industry Comparison
This section compares Ryman Healthcare Limited's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $250,407,165
- Average return on equity (ROE) among peers: -38.80%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Ryman Healthcare Limited (RHCGF) | $4.11 Billion | 16.11% | 1.94x | $1.39 Billion |
| Addus HomeCare Corporation (ADUS) | $113.86 Million | 16.82% | 0.44x | $1.75 Billion |
| agilon health Inc (AGL) | $126.73 Million | -319.84% | 9.03x | $166.17 Million |
| Airsculpt Technologies Inc (AIRS) | $123.68 Million | 6.13% | 0.45x | $16.62 Million |
| Amedisys Inc (AMED) | $454.23 Million | -18.40% | 0.61x | $3.26 Billion |
| AMN Healthcare Services Inc (AMN) | $347.86 Million | 23.54% | 1.53x | $624.22 Million |
| American Shared Hospital Service (AMS) | $20.85 Million | 8.48% | 1.33x | $7.93 Million |
| American Oncology Network Inc. (AONC) | $226.04 Million | -0.05% | 0.10x | $112.23 Million |
| Ardent Health Partners, Inc. (ARDT) | $1.08 Billion | 4.65% | 3.71x | $225.22 Million |
| Arem Pacific Corporation (ARPC) | $-45.09K | 0.00% | 0.00x | $246.12K |
| Astrana Health Inc (ASTH) | $8.55 Million | -109.27% | 1.29x | $1.08 Billion |